Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cellsŁukasz Skalniak, Tad A. Holak|Oncotarget|2017Cited by 308
Human and mouse PD-L1: similar molecular structure, but different druggability profilesKatarzyna Magiera‐Mularz, Łukasz Skalniak|iScience|2020Cited by 106
A PD-1/PD-L1-Sensitive Co-culture-Based Primary T-Cell Activation AssayJustyna Kocik-Krol, Łukasz Skalniak|Methods in molecular biology|2025Cited by 1
Balancing cell cycle arrest and immune activation: A synergistic window for idasanutlin and anti-PD-1 therapy in a syngeneic mouse modelAneta Nieznanska, Łukasz Skalniak|Biomedicine & Pharmacotherapy|2025Cited by 1